Amphetamines/Anorexiants/Stimulants

The phrase "Amphetamines/Anorexiants/Stimulants" represents an administrative formulary grouping rather than a single standardized pharmacological class

The phrase "Amphetamines/Anorexiants/Stimulants" represents an administrative formulary grouping rather than a single standardized pharmacological class

It encompasses central nervous system stimulants, amphetamine derivatives, and sympathomimetic appetite suppressants Clinically, members of this group are indicated for conditions requiring promoted wakefulness or neurobehavioral regulation, such as attention-deficit/hyperactivity disorder and narcolepsy, or for short-term appetite suppression in the management of exogenous obesity

It encompasses central nervous system stimulants, amphetamine derivatives, and sympathomimetic appetite suppressants

These agents primarily function by increasing synaptic concentrations of monoamine neurotransmitters—principally norepinephrine and dopamine—through enhanced release and reuptake inhibition

These agents primarily function by increasing synaptic concentrations of monoamine neurotransmitters—principally norepinephrine and dopamine—through enhanced release and reuptake inhibition Clinically, members of this group are indicated for conditions requiring promoted wakefulness or neurobehavioral regulation, such as attention-deficit/hyperactivity disorder and narcolepsy, or for short-term appetite suppression in the management of exogenous obesity

Clinically, members of this group are indicated for conditions requiring promoted wakefulness or neurobehavioral regulation, such as attention-deficit/hyperactivity disorder and narcolepsy, or for short-term appetite suppression in the management of exogenous obesity